| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9488 |
| Human Intestinal Absorption | HIA+ | 0.9888 |
| Caco-2 Permeability | Caco2+ | 0.8326 |
| P-glycoprotein Substrate | Non-substrate | 0.6321 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9598 |
| Non-inhibitor | 0.9277 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9266 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5152 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7886 |
| CYP450 2D6 Substrate | Non-substrate | 0.8956 |
| CYP450 3A4 Substrate | Non-substrate | 0.6982 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.8326 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8808 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9554 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9578 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9484 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9647 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9322 |
| Non-inhibitor | 0.8868 |
| AMES Toxicity | Non AMES toxic | 0.9865 |
| Carcinogens | Non-carcinogens | 0.6452 |
| Fish Toxicity | High FHMT | 0.9144 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9990 |
| Honey Bee Toxicity | High HBT | 0.6691 |
| Biodegradation | Ready biodegradable | 0.8795 |
| Acute Oral Toxicity | IV | 0.6378 |
| Carcinogenicity (Three-class) | Non-required | 0.7057 |